See more : Intellian Technologies, Inc. (189300.KQ) Income Statement Analysis – Financial Results
Complete financial analysis of Divi’s Laboratories Limited (DIVISLAB.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Divi’s Laboratories Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Vishnu Chemicals Limited (VISHNU.BO) Income Statement Analysis – Financial Results
- British Smaller Companies VCT 2 plc (BSC.L) Income Statement Analysis – Financial Results
- Fire Rock Holdings Limited (1909.HK) Income Statement Analysis – Financial Results
- RPMGlobal Holdings Limited (RUL.AX) Income Statement Analysis – Financial Results
- Scandi Standard AB (publ) (0QVR.L) Income Statement Analysis – Financial Results
Divi's Laboratories Limited (DIVISLAB.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.divislabs.com
About Divi's Laboratories Limited
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 78.45B | 77.68B | 87.99B | 68.58B | 52.91B | 48.04B | 38.07B | 40.53B | 37.76B | 31.15B | 25.32B | 21.45B | 18.64B | 13.07B | 9.42B | 118.03B | 10.33B | 7.25B | 3.81B |
| Cost of Revenue | 46.01B | 30.54B | 29.67B | 23.24B | 21.09B | 18.25B | 15.34B | 15.34B | 15.05B | 12.13B | 9.14B | 7.99B | 8.88B | 5.13B | 4.71B | 6.25B | 4.75B | 3.67B | 2.03B |
| Gross Profit | 32.44B | 47.14B | 58.32B | 45.34B | 31.83B | 29.79B | 22.73B | 25.19B | 22.71B | 19.02B | 16.18B | 13.46B | 9.76B | 7.94B | 4.70B | 111.79B | 5.58B | 3.58B | 1.78B |
| Gross Profit Ratio | 41.35% | 60.69% | 66.28% | 66.11% | 60.15% | 62.00% | 59.71% | 62.15% | 60.14% | 61.05% | 63.90% | 62.77% | 52.34% | 60.77% | 49.97% | 94.71% | 53.99% | 49.35% | 46.74% |
| Research & Development | 790.00M | 300.50M | 202.90M | 149.70M | 111.40M | 106.00M | 101.10M | 431.18M | 309.24M | 276.62M | 253.91M | 239.99M | 188.59M | 159.81M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.25B | 1.25B | 1.09B | 831.40M | 746.90M | 542.30M | 905.30M | 428.04M | 378.80M | 342.03M | 295.15M | 219.54M | 1.07B | 1.08B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 900.00M | 1.14B | 1.27B | 1.24B | 853.60M | 730.80M | 640.20M | 674.74M | 560.36M | 519.30M | 442.20M | 512.94M | 58.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.15B | 2.39B | 2.36B | 2.07B | 1.60B | 1.27B | 1.55B | 1.10B | 939.15M | 861.33M | 737.36M | 732.48M | 1.12B | 1.08B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 3.39B | 3.45B | 20.02B | 16.96B | 13.71B | 11.31B | 9.82B | 22.36M | 18.52M | 6.57M | 11.41M | 3.24M | 17.24M | 1.96B | 1.76B | 1.07B | 1.80B | 1.38B | 724.41M |
| Operating Expenses | 14.17B | 26.89B | 22.58B | 19.18B | 15.42B | 12.69B | 11.47B | 11.53B | 9.69B | 8.63B | 6.89B | 6.06B | 3.45B | 3.20B | 1.76B | 1.07B | 1.80B | 1.38B | 724.41M |
| Cost & Expenses | 59.80B | 57.43B | 52.25B | 42.42B | 36.50B | 30.94B | 26.81B | 26.87B | 24.74B | 20.76B | 16.03B | 14.05B | 12.33B | 8.33B | 6.47B | 7.32B | 6.55B | 5.05B | 2.75B |
| Interest Income | 3.01B | 2.05B | 689.60M | 572.40M | 66.60M | 74.80M | 43.50M | 54.81M | 81.79M | 46.46M | 60.98M | 27.27M | 7.00M | 4.66M | 0.00 | 8.65M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 30.00M | 6.70M | 3.70M | 3.90M | 55.40M | 21.20M | 5.50M | 11.94M | 9.65M | 5.66M | 9.13M | 7.54M | 37.43M | 22.04M | 27.79M | 106.23B | 0.00 | 4.38B | 0.00 |
| Depreciation & Amortization | 3.78B | 3.43B | 3.12B | 2.56B | 1.86B | 1.69B | 1.42B | 1.23B | 1.18B | 1.36B | 921.16M | 769.48M | 620.82M | 533.96M | 514.85M | 478.51M | 356.80M | 223.46M | 148.21M |
| EBITDA | 25.43B | 27.14B | 39.97B | 29.24B | 20.13B | 20.27B | 13.76B | 15.21B | 15.12B | 12.11B | 10.85B | 8.60B | 7.45B | 5.26B | 4.40B | 5.00B | 4.13B | 2.42B | 1.21B |
| EBITDA Ratio | 32.42% | 34.92% | 45.43% | 42.65% | 36.96% | 41.64% | 36.19% | 37.46% | 39.77% | 39.03% | 43.03% | 40.08% | 39.15% | 40.39% | 46.69% | 94.20% | 40.00% | 33.34% | 31.62% |
| Operating Income | 18.31B | 23.69B | 36.86B | 26.70B | 17.69B | 18.31B | 12.35B | 13.95B | 13.84B | 10.80B | 9.97B | 7.83B | 6.68B | 4.75B | 3.88B | 110.71B | 3.77B | 2.19B | 1.06B |
| Operating Income Ratio | 23.34% | 30.50% | 41.89% | 38.93% | 33.44% | 38.12% | 32.45% | 34.42% | 36.64% | 34.67% | 39.39% | 36.50% | 35.82% | 36.31% | 41.22% | 93.80% | 36.55% | 30.26% | 27.73% |
| Total Other Income/Expenses | 3.32B | 3.43B | 1.11B | 512.80M | 1.79B | 238.50M | -41.50M | 3.54M | 92.07M | -77.71M | -65.72M | -15.63M | 129.94M | -22.04M | -27.79M | 1.11B | -92.95B | -4.38B | -2.11B |
| Income Before Tax | 21.63B | 23.69B | 36.84B | 26.66B | 18.19B | 18.55B | 12.31B | 13.95B | 13.78B | 10.72B | 9.91B | 7.81B | 6.81B | 4.72B | 3.85B | 4.48B | 3.77B | -2.19B | 1.06B |
| Income Before Tax Ratio | 27.57% | 30.49% | 41.86% | 38.87% | 34.39% | 38.62% | 32.34% | 34.42% | 36.49% | 34.42% | 39.13% | 36.42% | 36.51% | 36.14% | 40.92% | 3.80% | 36.55% | -30.26% | 27.73% |
| Income Tax Expense | 5.63B | 5.45B | 7.23B | 6.82B | 4.43B | 5.02B | 3.54B | 3.35B | 2.66B | 2.21B | 2.18B | 1.79B | 1.47B | 431.05M | 449.91M | 315.87M | 299.01M | 333.80M | 361.48M |
| Net Income | 16.00B | 18.24B | 29.60B | 19.84B | 13.77B | 13.53B | 8.77B | 10.60B | 11.12B | 8.52B | 7.73B | 6.02B | 5.33B | 4.29B | 3.40B | 4.17B | 3.48B | 1.86B | 695.34M |
| Net Income Ratio | 20.40% | 23.48% | 33.64% | 28.93% | 26.02% | 28.16% | 23.03% | 26.16% | 29.44% | 27.34% | 30.54% | 28.07% | 28.61% | 32.84% | 36.14% | 3.53% | 33.66% | 25.65% | 18.25% |
| EPS | 60.27 | 68.69 | 111.52 | 74.75 | 51.85 | 50.96 | 33.04 | 39.95 | 42.41 | 32.08 | 29.13 | 22.68 | 20.10 | 16.21 | 13.06 | 16.10 | 13.46 | 7.25 | 2.71 |
| EPS Diluted | 60.27 | 68.69 | 111.52 | 74.75 | 51.85 | 50.96 | 33.04 | 39.95 | 42.41 | 32.08 | 29.13 | 22.68 | 20.10 | 16.20 | 13.03 | 15.94 | 13.31 | 7.16 | 2.66 |
| Weighted Avg Shares Out | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.35M | 264.82M | 260.74M | 258.86M | 258.23M | 256.45M | 256.37M |
| Weighted Avg Shares Out (Dil) | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.35M | 264.93M | 261.23M | 261.46M | 261.22M | 259.51M | 261.29M |
Source: https://incomestatements.info
Category: Stock Reports